龙沙集团(场外交易代码:LZAGY)交易量激增——现在是买入时机吗?- MarketBeat
Lonza Group (OTCMKTS:LZAGY) Sees Large Volume Increase - Time to Buy? - MarketBeat
生物技术与制药领域的最新动态
Lonza Group (OTCMKTS:LZAGY) Sees Large Volume Increase - Time to Buy? - MarketBeat
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Stock Titan
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Yahoo Finance
Industry Roundtable: Small-Molecule APIs: What’s in Store for 2026? - DCAT Value Chain Insights
Why Illumina (ILMN) Is Up 5.9% After CMS Backs TruSight Oncology Comprehensive Reimbursement - simplywall.st
NIH imposes full ban of aborted fetal tissue in research
High court picked Hikma’s ‘skinny label’ fight after letting the issue ‘percolate’
Investors load Corxel with $287M for a ‘differentiated’ obesity pill
Drugmakers spent less on Washington lobbying in 2025's final quarter
Janux’s tumor-activated platform draws BMS in potential $850M deal
Appointments and advancements for Jan. 22, 2026
Financings for Jan. 22, 2026
Other news to note for Jan. 22, 2026
Regulatory actions for Jan. 22, 2026
Bristol Myers buys into Janux’s ‘masked’ T cell engagers
Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing
FDA lays out new path to speed development of multiple myeloma drugs
Corcept's drug extends patients' lives in key ovarian cancer study
BioMarin vets form Mendra to ‘modernize’ rare disease drug development
China-founded pharma Corxel raises up to $287M for oral GLP-1